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Aging in the kidney can cause albuminuria, and discovering
molecular mechanisms responsible for this might offer
a new perspective on the etiology of this abnormality.
Haplotype association mapping in the mouse is a novel
approach which uses the haplotypes of the relatively closely
related mouse inbred strains and the phenotypic variation
among these strains to find associations between haplotypes
and phenotype. The albumin-to-creatinine ratios, a measure
of urinary albumin excretion, were determined in 30 inbred
mouse strains at 12, 18, and 24 months of age. Mapping was
performed for males and females separately at all three time
points using a high density set of 63,222 single-nucleotide
polymorphisms to determine genetic loci involved in
albuminuria. One significant and eight suggestive loci
were found, some of which map to previously identified
loci for traits associated with kidney damage in the
mouse, but with a much higher resolution thus narrowing
their chromosomal location. These nine loci were then
compared with genome-wide association scans for diabetic
nephropathy (DN) in human type I diabetes. Our study found
that two of the nine mouse loci for age-related albuminuria
were significantly associated with DN and consistent across
male and female strata. This suggests common underlying
genes predispose to kidney disease in mice and humans.
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The kidneys are particularly affected by age. Not only does
aging in other organs affect the kidneys, but their decline
also contributes directly to the pathogenesis of many other
age-related pathologies.1 Many changes take place in the
kidney during aging: functional changes, such as the decline
in glomerular filtration rate2 and reduction in sodium homeo-
stasis;3 vascular changes leading to atherosclerosis, hyperplasia,
and hypertension;4 and structural changes in the glomeruli,5
tubuli, and the interstitium. These changes involve various
mechanisms and pathways, and it is difficult to identify the
main causal players leading to these changes.
It is becoming increasingly recognized in experimental
models that both sex and genetic background have a
significant function in the scale and progression of kidney
damage associated with age.1 These differences can be used
in phenotype-driven approaches to identify the causal factors
responsible for this variation.
In recent years, several studies analyzed quantitative trait
loci (QTL) for urinary albumin on crosses between different
rat6 and mouse strains.7,8 These studies identified genetic loci
linked to kidney damage, but all were performed on relatively
young animals (3–5 months). Thus, the reported loci may not
be particularly relevant to age-related kidney disease in humans.
In this study, we examined the progression of kidney
damage using urinary albumin-to-creatinine ratios (ACR)
in male and female mice from 30 inbred strains for up
to 24 months, well into old age. To localize candidate
chromosomal regions associated with increased albuminuria,
we used haplotype association mapping (HAM), a recently
developed approach that utilizes high-density single-nucleo-
tide polymorphism (SNP) data from many inbred strains to
identify chromosomal haplotypes associated with phenotypic
traits of interest.9,10 Finally, as the ultimate goal of genetic
studies using animal models is to find genes relevant to
human disease, we identified homologous human chromo-
somal intervals for our mouse loci and tested them for
significant association with nephropathy in the genome-wide
association scan (GWAS) data obtained in the GoKinD
collection of type I diabetic patients.11
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RESULTS
Albumin-to-creatinine ratios for mouse inbred strains
The 30 inbred mouse strains used in this study are listed in
Table 1. Our data for urinary albumin and creatinine
measurements for male and female mice of all strains are
available at the Mouse Phenome Database (www.jax.org/
phenome). From these values, the albumin (in mg) to
creatinine (in g) ratio (ACR) was calculated at 12, 18, and
24 months of age (Figure 1). At each time point, we observed
large variability in ACR measurements among strains. Many
assayed strains, including BALB, C57BR, and BLKS, have low
ACR values that remain stable over time. Several strains,
including KK, PWD, and BUB, show increased ACR as early
as 12 months. Interestingly, among these strains, the increases
seem to be sex specific. These sex differences are also
apparent in the progression of ACR over time. Moreover, we
see a faster increase in ACR for A, B10, FVB, NZW, PWD,
and WSB males compared with females (Figure 2a). Yet
contrary to this, we see a more rapid progression of ACR in
female mice in the BUB, KK, MRL, NON, and SJL strains
(Figure 2b). As the median lifespan for strains used in this
study is 22 months (individual strain data can be obtained
from the Mouse Phenome Database), not all strains were
available for analysis at the later time points. As different
cohorts for each strain were used for the different time
points, some strains had enough animals per group at 24
months; some strains, however, had no animals left even at 18
months of age. For males, there is no data for CAST, SJL, and
BTBR at 18 months, and for CAST, PL, KK, NZO, and P at 24
months. For females, there is no data for PL at 18 months,
and for CAST, BTBR, KK, MRL, NOD, NZO, and PL at 24
months.
Haplotype association mapping
We used a total of 63,222 SNPs (average spacing of 40.53 kb
between each SNP) to reconstruct haplotypes across the
genomes of all 30 mouse strains. We then used the F-test
statistics to obtain a high-resolution map of associated
intervals and estimated the strength of association between
genotypes across these haplotypes and the albuminuria
phenotype (as measured by ACR) across all strains. Figure 3
summarizes the genome-wide HAM results for ACR at 12,
18, and 24 months in males and females. We estimated
family-wise error rate at a-levels of 0.05 and 0.20 through
permutation testing to identify significant and suggestive
HAM peaks. Only one peak, on chromosome (Chr) 2 in
18-month-old males, reached the stringent level of signifi-
cance. We believe, however, that because of the genetic related-
ness between the genomes of laboratory strains, the power may
be low, resulting in an overly stringent genome-wide threshold
that fails to detect biologically relevant peaks. Therefore, we
considered ao0.20 to be suggestive evidence of true genetic
associations. We identified 22 peaks across the genome that
corresponded to this threshold. Careful examination of the
haplotypes in the associated intervals, by sorting the strains
by haplotype and their association with the phenotype,
identified several peaks that were associated with a haplotype
in only one strain. Other associations, however, were not
entirely convincing with the current data set, as there was
association with only one SNP. In these cases we went to the
original NIEHS and Broad SNP data sets that were used to
create the data set that we used for the analysis, this to see
whether the association expanded over a larger region.
Unfortunately, the original data sets have too many missing
values in these regions for the strains that we used. Denser
SNP data and phenotype data from more strains are needed
to provide a conclusive answer. Nine loci, ranging in size
from 100 to 650 kb, with an average of two genes per locus,
were determined to be robust associations (Table 2).
The strongest association with ACR was mapped to a
180 kb region on Chr 2 in 18-month-old male mice
(P¼ 1.9 1010). Two genes, Cyp24a1 and Fdn4, reside
within this interval. The most significant association in
female mice (P¼ 3.5 1010) occurred in 12-month-old
animals and was localized to a 100 kb region on Chr 3 that
contains Negr1, which encodes the neuronal growth reg-
ulator-1. Among 24-month-old mice, the strongest associa-
tion in male and female mice occurred at the Ripk2 locus on
Chr 4 (P¼ 1.2 108) and at the Atic/Fn1 locus on Chr 1
(P¼ 3.7 108), respectively. Interestingly, with the excep-
tion of the locus on Chr 11, which was identified in males at
24 months and showed a suggestive peak at 18 months, each
of the associated loci are unique, with no overlap between
sexes and across the measured time points.
Concordance between albuminuria-associated loci in mice
and diabetic nephropathy susceptibility genes in humans
To assess whether genomic regions associated with albumi-
nuria in mice were also associated with nephropathy in
humans, we analyzed genetic data from the GoKinD
collection at syntenic human chromosomal regions corre-
sponding to each of the albuminuria-associated loci identi-
fied using HAM. For each locus, genotypic data from a recent
GWAS of this collection were enhanced by the imputation of
ungenotyped SNPs.11 To minimize redundancy between
highly correlated SNPs, 1085 tagging SNPs were identified
across these 9 loci from among a total of 4329 available SNPs
(including 671 genotyped SNPs and 3658 imputed HapMap
SNPs) using an r2 threshold 40.80 and examined for
evidence of association. Among 885 control subjects with
Table 1 | The 30 inbred mouse strains used in the aging study
and their abbreviations as used in the text
129S1/SvImJ (129) C57BLKS/J (BLKS) LP/J (LP) PWD/PHJ (PWD)
A/J (A) C57BR/cdJ (C57BR) MRL/J (MRL) RIIIS/J (RIIIS)
BALB/cByJ (BALB) C57 L/J (C57 L) NOD.B10Sn-H2b/
J (NOD)
SJL/J (SJL)
BTBR T+ tf/J (BTBR) CAST/EiJ (CAST) NON/LtJ (NON) SM/J (SM)
BUB/BnJ (BUB) CBA/J (CBA) NZO/H1LtJ (NZO) SWR/J (SWR)
C3H/HeJ (C3H) DBA/2J (D2) NZW/LacJ (NZW) WSB/EiJ (WSB)
C57BL/6J (B6) FVB/NJ (FVB) P/J (P)
C57BL/10J (B10) KK/J (KK) PL/J (PL)
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type I diabetes (T1D) and normoalbuminuria and 820 case
subjects with T1D and advanced diabetic nephropathy (DN),
we identified significant associations (Po0.05/1,085 tag
SNPs¼ 4.6 105) at two unique SNPs across the nine
albuminuria-associated loci (Table 3). We observed the
strongest association at rs1411766 (odds ratio¼ 1.41,
P¼ 1.8 106), an SNP located in an intergenic region on
human chromosome 13q and within the syntenic
albuminuria-associated locus identified on mouse Chr 8
(Figure 4). This association maps B384 kb distal of the
MYO16 (myosin heavy chain Myr 8) gene and 120 kb
proximal of IRS2 (insulin receptor substrate 2). We observed
a second significant association at an imputed SNP
(rs6671557, odds ratio¼ 1.97, P¼ 2.8 105) within
intron 3 of NEGR1 (neuronal growth regulator 1) on
human chromosome 1p, a region syntenic to the
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Figure 1 |Mean albumin-to-creatinine ratios (ACR) for males and females from all 30 mouse strains. For females at 12 (a), 18 (c), and 24
months (e), and males at 12 (b), 18 (d), and 24 months (f) with s.d.
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albuminuria-associated locus identified on mouse Chr 3.
rs6671557 was subsequently genotyped in the GoKinD
samples, and we confirmed the association with the imputed
data (P¼ 4.9 105). We analyzed both SNPs according to
sex. For each, the strength of the association was consistent
across the male and female strata.
DISCUSSION
Our project objectives were to investigate the genetics of the
progression of kidney damage as measured by the ACR in
aging mice, and to identify candidate genes. Our strategy
included HAM, a recently developed approach that uses
haplotypes reconstructed from high-density SNP data sets to
look for associations between chromosomal regions and a
particular trait of interest. We previously used HAM to
confirm several reported QTL for high-density lipoprotein
cholesterol levels and cholesterol gallstones.12 Because of the
higher resolution of HAM versus linkage mapping, in
addition to confirming these associations, we more precisely
mapped these loci to smaller genomic intervals and identified
putative candidate genes within these regions.
Using HAM, we identified a total of nine loci associated
with albuminuria, and hence renal damage, in aging mice.
The stringent method we used to establish the threshold for
significance in our analysis identified one significant peak
(ao0.05) and nine association peaks (ao0.20). After close
examination of individual strain haplotypes, we determined
these to be true associations. As the HAM methodology is
still in its infancy, the most appropriate multiple testing
correction method to determine thresholds for significance is
still unknown. Owing to this uncertainty, and to avoid the
risk of inflation of a type I error in applying a more liberal
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A/J C57BL/10J FVB/NJ NZW/LacJ PWD/PhJ WSB/EiJ
500
300
100
0
m
g/
g
m
g/
g
12 18 24 12 18 24 12 18 2412 12 24
200
200
150
100
50
0
0
300
100
200
0
400
1000
500
0
1500
1000
0
1500
1000
500
0
1500
1000
500
200
0
400
800
600
200
0
400
600
600
0
200
1000
600
200
0
400
800
600
12 18 24 12 18 24
12 18 24 12 18 24 12 18 24 12 18 24 12 18 24
Figure 2 | Sex differences in the susceptibility and progression
of albumin-to-creatinine ratio (ACR) are strain dependent.
(a) Strain in which males (squares) are more susceptible and
have a higher increase of ACR over time compared with females
(circles), and (b) the opposite effect, where females are more
susceptible and have a higher increase of ACR over time compared
with males.
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Figure 3 |Genome-wide scans for females at 12 (a), 18 (b), and 24 months (c), and males at 12 (d), 18 (e), and 24 months (f)
using the log10 P-values. Family-wise error rate (FWER) at a levels of 0.05 and 0.20 were estimated through permutation testing
to identify significant and suggestive haplotype association mapping peaks.
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threshold, it is very likely that the method we used for these
calculations in our analysis is too conservative given the
cosegregation of highly correlated SNPs within each haplo-
type block.13 The impact of missing data on our finding
depends on the pattern. For strains with missing ACR data
that probably would have been high, we would have
underestimated the significance of certain haplotype regions.
For example, in both KK and MRL mice, the ACR at 18
months is much higher than that at 12 months, and it is likely
that these two strains would still have high ACR at 24
months. Missing these two strains at 24 months would have
reduced our power to detect significant haplotype regions
and increased our chance of false-negative findings.
Each of the albuminuria-associated intervals contains
from one to as many as seven known genes. Although some
of these genes have no reported associations with kidney-
related phenotypes, several, including Fn1 and Aspa, have
been implicated in the pathogenesis of age-related kidney
damage. Fn1, on Chr 1, is a very interesting candidate gene
that has recently been linked to glomerulopathy with
fibronectin deposits (GFND, MIM 601894) in humans. First
described by Strom et al.,14 this heritable kidney disease is
characterized by proteinuria, microscopic hematuria, and
hypertension that ultimately progresses to end-stage renal
disease (ESRD). Recently, three heterozygous missense
mutations (W1925R, L1974R, and Y973C) in human FN1
have been identified as the cause of GFND in six unrelated
pedigrees.15 Aspa, on Chr 11, encodes aspartoacyclase.
Mutations in the human gene are known to cause Canavan
disease, a neurodegenerative disorder that leads to the spongy
degeneration and astrocytic swelling of neuronal cells.16
Interestingly, Aspa is highly expressed in the kidney and,
moreover, Aspa/ mice show an 18% increase in lipid
incorporation in the kidney.17 Although these mice have not
been tested for albuminuria, this increase in lipid could lead
to renal damage with albuminuria.18
In mice, both genetic background and sex have been
identified as determinants of the rate of progression of age-
related kidney damage.1 We observed a high degree of
variability with the progression of ACR over time between
both strain and sex. We do not observe a general trend
toward higher ACR and a faster increase in ACR in males, but
Table 2 | Summary of the haplotype association mapping peaks for both sexes at the different time points
Age (months) Sex Chr. Locus (Mb) Nominal P-value Genes in interval
12 F 3 156.92–157.02 3.5 1010 Negr1
18 F 7 36.62–36.74 2.7 109 No gene
M 2 170.30–170.48 1.9 1010 Cyp24a1, Fdn4
M 6 65.60–66.57 4.3 109 Prdm5
M 8 10.60–10.95 4.3 109 Myo16
24 F 1 71.52–71.68 1.2 108 Atic, Fn1
F 18 82.72–82.94 1.6  108 Mbp, Zfp236
M 4 16.08–16.36 3.7 108 Ripk2
M 11 73.05–74.10 3.7 108 Trpv1, Trpv3, Aspa, Spata22, Olfr381, Olfr389, Olfr392
For each locus the chromosomal location (mouse genome Build 37), the P-value calculated by F-statistics, and the annotated genes within the interval (Ensembl database)
are given. The genome-wide type I error thresholds were estimated based on 1000 permutation tests. The P-value thresholds at ao0.02 level corresponds to a nominal value
of 1.9 109 for 12 month females, 3.4 109 for 18 month females, 3.0 108 for 24 month females, 1.6 108 for 18 month males, and 6.2 107 for 24 month males.
Table 3 | Summary of associations with diabetic nephropathy in genome-wide association scan (GWAS) data from the GoKinD
collection at syntenic human chromosomal regions for mouse albuminuria-associated loci
Mouse HAM peak regionsa Human GWA scan resultsb
Chr.
Locus
(Mb)
Haplotype
Size (kb) Gene(s) within interval Chr.
Candidate gene
interval (Mb)c SNPd P-value Nearest gene
1 71 154.3 Atic, Fn1 2 215.8–216.1 rs13002052 0.02 ATIC
2 170 184.1 Cyp24a1, Pfdn4 20 52.2–52.4 rs964293 0.03 PFDN4
3 157 104.8 Negr1 1 71.5–72.6 rs6671557 4.9 105 NEGR1
4 16 281.1 Ripk2 8 90.7–90.9 rs13276910 8.7 103 RIPK2
6 66 962.6 Prdm5 4 121.2–122.2 rs17051145 0.02 PRDM5
7 36 119.2 No gene 19 37.3–37.6 rs10403365 0.01 ZNF507
8 10 354.8 Myo16 13 108.0–109.2 rs1411766 1.8 106 IRS2
11 73 1047.3 Trpv1, Trpv3, Aspa, Spata22, Olfr381, Olfr389, Olfr392 17 3.0–3.5 rs9904733 0.01 SHPK
18 82 217.2 Mbp, Znf236 18 72.5–72.9 rs4891196 0.02 ZNF236
Abbreviations: HAM, haplotype association mapping; SNP, single-nucleotide polymorphism.
aChromosomal loci and gene annotations are in reference to NCBI Build 37.1 of the mouse genome.
bChromosomal loci and gene annotations are in reference to NCBI Build 36.1 of the human genome.
cCandidate gene intervals correspond to syntenic human chromosomal regions. For genes partially contained within the syntenic albuminuria-associated regions, these
intervals were extended to include ±50 kb of sequence flanking the gene(s) contained within the associated genomic intervals.
dMost strongly associated SNPs in the GoKinD collection within each candidate gene interval.
Bold values above sign threshold Po4.6 105.
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conclude that these phenotypes are highly strain dependent
(Figure 2). The sex differences in kidney damage between
males and females could be influenced by androgen and
estrogen. For example, damage to the kidney with age,
including vascular changes, can be limited by castration or
estrogen treatment in males.19,20 As these differences are
clearly strain dependent, this suggests that the underlying
genetic factors we identify in genetic studies are either
interacting themselves with these hormones or affecting
pathways that are influenced by androgen and estrogen.
Using QTL analysis to compare our HAM results with
previously identified loci for albuminuria and renal damage-
related parameters (Figure 5), we see overlaps at only four
QTL (chromosomes 2, 4, 7, and 11). This is not entirely
surprising, as these QTL analyses were performed using
relatively young mice (between 3 and 5 months). Therefore,
these studies were primarily designed to identify loci involved
in early-onset albuminuria. More remarkably, as the ultimate
goal of genetic studies using animal models is to find genes
that are relevant in human disease, is the concordance
between two of the nine mouse loci identified using HAM
and homologous human chromosomal regions identified in
our analysis of GWAS data from the GoKinD collection
(Figure 5). We observed the strongest association among
these concordant findings at an SNP located in an intergenic
region on human chromosome 13q and within the syntenic
albuminuria-associated locus identified on mouse Chr 8
between Myo16 and Irs2. Interestingly, significant evidence of
linkage was also recently identified at this same locus in
studies of patients with nondiabetic ESRD and all-cause
ESRD.21,22 We observed a second significant association at an
SNP within intron 3 of NEGR1 on human chromosome 1p, a
region syntenic to the albuminuria-associated locus identified
on mouse Chr 3. Although no evidence of association was
observed in our analysis of the GoKinD data among the
remaining loci identified in our study, evidence of linkage has
been reported at three syntenic loci in other human studies of
nephropathy.23–25 Specifically, Schelling et al.25 found sig-
nificant evidence of linkage with glomerular filtration rate in
patients with type II diabetes at position 71.24–75.95Mb on
human chromosome 18, a region homologous to the mouse
chromosome 18 locus identified in our study. Loci identified
by Puppala et al.23 (position 213.38–236.13Mb on human
chromosome 2) and Chen et al.24 (position 0.00–14.60Mb on
human chromosome 17) in diabetes-associated nephropathy
in human are syntenic to our albuminuria-associated loci on
mouse chromosomes 1 and 11, respectively. In addition, we
have also recently reported significant linkage near the human
locus syntenic to the HAM signal on mouse chromosome 1
(position 195.00–213.00Mb on human chromosome 2).26
Our imputation of ungenotyped SNPs in the GoKinD
collection allowed us to fine-map each of the homologous
human chromosomal intervals for our mouse loci. More
specifically, our analysis of these data identified several
variants in strong linkage disequilibrium (r240.80) with the
leading SNPs on chromosomes 1 (rs6671557) and 13
(rs1411766) (Supplementary Table 1). In total, 21 highly
correlated SNPs were identified in a 172.4 kb region spanning
introns 2, 3, and 4 of NEGR1, whereas fivr SNPs were
identified in a 21.4 kb intergenic region at the MYO16-IRS2
locus. Although additional analysis is necessary to pinpoint
the causative variants at these regions, including resequen-
cing of these regions (to uncover additional correlated SNPs)
and functional interrogation of these variants, our analysis of
these data provide a subset of candidate SNPs for further
investigation at each of these loci.
For each interval, experimental genotypes in the GoKinD
collection were enhanced by the imputation of ungenotyped
SNPs using MaCH (www.sph.umich.edu/csg/abecasis/MACH/).
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Figure 4 |Genetic associations at albuminuria-associated
loci in human genome-wide association (GWA) scan data.
(a) Association data (–log10 P-values calculated using the
Cochran–Mantel–Haenszel method, adjusting for gender and
GoKinD subcollection) from Type I diabetes patients with and
without advanced diabetic nephropathy from the GoKinD collection
are shown for 114 tag single-nucleotide polymorphisms (SNPs),
including 14 genotyped (solid triangles) and 100 imputed (open
triangles) SNPs, spanning the candidate gene interval on human
chromosome 1p (position 71,537,304–72,570,865, dashed lines).
The examined interval extends from the syntenic human
chromosomal region (position 71,537,304–71,716,227)
corresponding to the albuminuria-associated haplotype on
mouse Chr 3 (position 156,918,173–157,022,996) and spans
50 kb upstream of NEGR1’s transcription start site. rs6671557
is located at position 71,992,909 (IVS3þ 21,534 relative to
NEGR1). The entire candidate chromosomal interval on human
chromosome 1p maps to mouse Chr 3. (b) Association data for
368 tag SNPs (71 genotyped and 297 imputed SNPs) analyzed in
the GoKinD collection are shown across the human chromosome
13q candidate gene interval (position 107,996,501–109,154,781).
This interval includes the syntenic human chromosomal region
(position 108,621,676–109,154,781), corresponding to the
albuminuria-associated haplotype on mouse Chr 8 (position
10,596,101–10,950,911), and extends 50 kb upstream of the
MYO16 gene. rs1411766 is located at position 109,050,161.
The two nearest genes, MYO16 and IRS2, are located approximately
384kb centromeric and 120kb telomeric of rs1411766. The candidate
chromosomal interval on human chromosome 13q solely maps to
mouse Chr 8.
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We identified a total of 4329 SNPs (including 671 genotyped
SNPs and 3658 imputed HapMap SNPs) across these nine
loci.
In this study, we did not find associations in the mouse for
the homologous loci on human 7p (near CPVL/CHN2), 9q
(near FRMD3), and 11p (near CARS) that were recently
shown to be significantly associated with DN in the GoKinD
collection.11 Interestingly, the concordant region for the 9q
locus is located near the peak markers on Chromosome 4 for
albuminuria QTL, identified in two different intercross
populations—(C57BL/6JA/J)F28 and (C57BL/6JDBA/
2J)F2,7 and a proteinuria QTL identified in a backcross
population—(C57BL/6JNZM)F1NZM.27
Concordance between mice and humans at these asso-
ciated loci suggests that the same underlying genes within
these regions contribute to kidney disease. Interestingly, as
with each of the albuminuria-associated loci identified using
HAM, the two concordant loci are sex-specific in mice. We
analyzed the GoKinD data to see if similar effects were also
present in human data, and found no significant differences
in allele frequencies between male and female patients. It is
possible that such an effect is present, but that because of the
‘outbred’ structure of this human population, we are not able
to detect differences between males and females over time. It
could also be that, although sex differences clearly have a
significant function in mice, no sex differences exist between
alleles at these same loci in humans. Once we identify the
underlying genes and the mechanism responsible for the sex
difference in mice (e.g., estrogen-regulatory elements in the
promoter), we will be able to more successfully examine
possible sex-specific effects in humans.
Apart from unique loci between males and females, we
also do not see overlap between loci at the different time
points. Two explanations are possible: first, different genes
could be involved at different stages in the disease process. Or
second, because different strains are affected at different time
points, different genes could be determining the difference
between affected and non-affected mice.
Why do we find overlap of loci associated with proteinuria
in human diabetic patients and loci associated with
albuminuria in aging mice? The most likely explanation is
that these loci are part of a common pathway for renal
disease. There is some evidence that these kinds of pathways
exist. One example is the NF-B pathway, which is increasingly
activated in glomeruli with age and which has a function in
glomerular failure.28 Some authors showed that this same
pathway was activated in DN.29 Maybe the diabetic environ-
ment has the same effect on these pathways as aging, or
maybe it even accelerates the progression of renal disease:
Gurley et al.30 and Qi et al.31 showed that, in several of the
same inbred strains we used in our study, inducing a diabetic
environment accelerates albuminuria. The concordance of
mouse and rat QTL for renal damage, although using
different models of disease (hypertension, systemic lupus
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Figure 5 |Mouse chromosomal map indicating significant haplotype association mapping (HAM) peaks (first letter is the sex,
number is the age in months) for previously found quantitative trait loci (QTL) related to renal damage QTL in the mouse.
Bars represent the 95% confidence interval. Within the bars, black stripes indicate the peak marker of the QTL, and the number indicates
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erythematosus, hyperlipidemia), also argues that common
genes lead to damage.6
In contrast to QTL studies, the HAM of ACR in inbred
strains presented here allows for the identification of small
genomic intervals associated with renal damage. Of course,
even these regions require further narrowing before we can
definitively identify candidate genes. However, the concor-
dance between our findings in mice and those in humans
suggests that the genes underlying kidney disease are highly
conserved between both species. In addition, this conserva-
tion allows us to combine both mouse and human data to
more precisely localize the candidate disease genes within the
genomic regions. Now, mouse–human comparative mapping,
region-specific haplotyping, additional mouse crosses, gene
sequencing and gene expression studies in both mice and
humans can be used to more readily identify the causal genes.
Once identified, the powerful genetic tools in the mouse,
including both knockout and transgenic technology, can be
used to test the effect of gene function (or dysfunction) on
the kidney.
MATERIALS AND METHODS
Mice and phenotype characterization
Groups of 10 males and 10 females from 30 different inbred strains
(Table 1) were obtained from The Jackson Laboratory, Bar Harbor,
ME. If any of the mice died during the experiment, they were
replaced with mice from the same strain. We housed mice in a
climate-controlled facility with a 12:12-h light–dark cycle and
provided free access to food and water throughout the experiment.
After weaning, we maintained mice on a chow diet (Lab diet 5K52,
PMI Nutritional International, Bentwood, MO, USA). We collected
urine samples at 12, 18, and 24 months, and measured albumin and
creatinine concentrations on a Beckman Synchron CX5 Chemistry
Analyzer (Fullerton, CA, USA). Actual mouse albumin concentra-
tions were calculated by linear regression from a standard curve
generated with mouse albumin standards (Kamiya Biomedical,
Seattle, WA, USA). All experiments were approved by The Jackson
Laboratory’s Animal Care and Use Committee.
Haplotype association mapping
We selected SNPs from the following sources: The Jackson
Laboratory, Oxford, Merck, GNF and Perlegen (see www.jax.org/
phenome for detailed information on the sources). We divided the
mouse genome into nonoverlapping 40 kb intervals, and in each
interval, selected one SNP based on the following criteria: high
number of polymorphisms among 25 widely used classical
laboratory strains, few missing genotypes, and even distribution
across the genome. A total of 63,222 SNPs were selected. Genotypes
that were missing in this set (due to technical failures for some of
the SNP markers for some of the strains) were imputed based on the
close relatedness of the strains. Missing genotypes are imputed at
each SNP locus as the allele by hidden Markov model. The strong
linkage disequilibrium found in dense set of SNP markers in the
laboratory mouse provides the basis for accurate imputation based
on observed genotypes. An hidden Markov model was applied,
fitting five states at each SNP, for the primary purpose of missing
genotype imputation and for the secondary purpose of haplotype
identification.32 A total of 580,781 missing genotypes (28.70%) were
imputed for this particular data set. All SNPs with imputed
genotypes had a confidence score over 0.6, and the average filling
accuracy of the imputed genotypes across the whole genome was
89.9%.
At each SNP, we determined a strain distribution pattern using
the hidden Markov model-smoothed haplotype states (hidden
Markov model path). We computed F-test statistics to measure the
strength of association between genotype and phenotype. Its
significance was estimated to detect haplotype groups with different
mean phenotypes. The segregation of strains into haplotype groups
varied widely over haplotype blocks; therefore P-values of the F-test
statistic were compared between haplotype blocks. We controlled
the type I error rate for multiple testing due to genome-wide
searching using family-wise error rate control.33 We shuffled the
strain label in the phenotype data and kept the genotype data intact.
The minimum P-value was recorded on each permutation;
percentiles of their distribution were used to provide approximate
multiple test-adjusted thresholds. The genome-wide type I error
thresholds were estimated based on 1000 permutation tests. Peaks
corresponding to P-value thresholds adjusted for global significance
were defined as significant at ao0.05 level. Owing to the close
genetic relationship between genomes of inbred laboratory strains,
HAM analysis has limited power to detect small genetic effects.
Furthermore, FWER methods generally yield conservative results. To
detect peaks that have small, but biologically relevant, genetic effects,
we chose to relax the protection against type I errors and consider
HAM peaks that exceeded an a of 0.20 to be suggestive evidence of
true genetic association. All analysis was carried out in the MATLAB
computing environment (The Mathworks, http://www.mathworks.
com), except the imputation of missing genotypes.
Analysis of DN-associated loci in GWAS data from the GoKinD
collection
We confirmed our findings in aging mice using GWAS data from the
GoKinD collection for syntenic human chromosomal regions
corresponding to the nine albuminuria-associated loci identified
using HAM.11 A detailed description of the GoKinD collection, a
large case–control population assembled to aid the identification of
genetic factors associated with DN in T1D, has been published
elsewhere.34 Briefly, subjects for the GoKinD collection were
recruited through two centers: the George Washington University
(GWU) Biostatistics Center and the Section of Genetics and
Epidemiology at the Joslin Diabetes Center (JDC). All subjects
enrolled in GoKinD had T1D diagnosed before age 31 years, began
insulin treatment within 1 year of their diagnosis, and were between
18 and 59 years of age at the time of enrollment. Controls had T1D
for at least 15 years, and persistent normoalbuminuria cases with
DN had either persistent proteinuria or ESRD (dialysis or renal
transplant).
Genotypes of the GoKinD collection were generated with the
Affymetrix 5.0 500K SNP Array (Santa Clara, CA, USA) by the
GAIN genotyping laboratory at the Eli and Edythe L. Broad
Institute. Quality control measures, including the analysis of
population substructure, resulted in 359,193 autosomal SNPs and
1705 Caucasian subjects (885 controls and 820 cases, 284 with
proteinuria and 536 with ESRD) suitable for statistical analysis.
Additional information on the clinical characteristics of cases and
controls used in the analysis, as well as the generation of the GWAS
data for the GoKinD collection, is provided in our previous
publication.11 In addition, rs6671557 was genotyped in the GoKinD
collection using Taqman (Applied Biosystems, Foster City, CA,
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USA) technology by the Genetics Core of the Diabetes and
Endocrinology Research Center at the JDC in accordance with the
manufacturer’s protocols. DNA samples used for genotyping this
SNP in the GoKinD collection were obtained through the National
Institute of Diabetes and Digestive and Kidney Diseases Central
Repository (www.niddkrepository.org/).
We identified syntenic human chromosomal regions for each of
the nine albuminuria-associated loci using the Ensembl Genome
Browser (www.ensembl.org/, Ensembl Homo sapiens version
52.36n, NCBI Build 36.1 and Ensembl Mus musculus version
52.37e, NCBI Build 37.1). We expanded candidate gene intervals to
include the entire sequence (including 50 kb of flanking sequence) of
all genes partially contained within these homologous regions. For
each interval, experimental genotypes in the GoKinD collection were
enhanced by the imputation of ungenotyped SNPs using MaCH
(www.sph.umich.edu/csg/abecasis/MACH/). We identified a total of
4329 SNPs (including 671 genotyped SNPs and 3658 imputed
HapMap SNPs) across these nine loci. To minimize redundancy
among highly correlated SNPs, we used the Haploview software
program (www.broad.mit.edu/mpg/haploview/) to assign these
SNPs to 1085 distinct linkage disequilibrium bins and select tagging
SNPs, using an r2 threshold40.80.35 Statistical association analyses
among these tag SNPs were performed using an additive allelic test
of association using the Cochran–Mantel–Haenszel procedure,
stratified by sex and GoKinD subcollection (JDC and GWU), as
implemented in PLINK.35
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